ACO Public Reporting Requirements

ACO Name and Location

Huntington Care Network ACO, LLC
100 W California Boulevard
Pasadena, California 91105

ACO Primary Contact

Primary Contact Name

Paula Verrette, MD

Primary Contact Phone Number

(626) 397-5555

Primary Contact Email Address

paula.verrette@huntingtonhospital.com

Organizational Information

ACO Participants:

ACO Participants

ACO Participant in Joint Venture

Pasadena Nephrology Corporation A Medical Group

N

Robert Siew

N

Alexis Anvekar MD Inc

N

Beauty Swe Md Inc

N

Wufaa Alrashid MD Inc

N

Elisa C Alvarado MD Inc

N

Daryl P. Banta, M.D., Inc.

N

Southern California Neurology Medical Group Inc

N

Syeda M F Ali MD Medical Corporation

N

Amy Savagian

N

Frederick Lee

N

Elisa Alvarado

N

Ayman Saad Md Inc

N

Arroyo Nephrology Associates

N

Jacklin Poladian MD Inc

N

Ashish B Patel Md Inc

N

Robert Siew MD

N

Dolores Figueroa M.D., A Professional Corporation

N

Huntington Pulmonary Medical Group

N

Amy Savagian MD Medical Corporation

N

The Leela Integrative Medicine Center Inc

N

Wufaa Alrashid

N

Philip Girard

N

Sylvia Preciado

N

Michael Gurevitch

N

Washington Medical Group

N

Pasadena Hospital Association Ltd

N

Joseph J. Pachorek, M.D., Inc., A California Medical Corporation

N

Nirmal Kumar, M.D., Inc., A Professional Corporation

N

Foothill Cardiology California Heart Medical Group, Inc.

N

Richard A Spitzer Md A Medical Corporation

N

John L. Easthope Jr., M.D. Inc.

N

S D Henry Md Inc

N

W. Allan Edmiston, MD, A Medical Corporation

N

Philip Girard

N

Gustavo A Alza Md A Medical Corporation

N

Frederick Lee

N

Foothill Pulmonary & Critical Care Consultants Medical Group, Inc.

N

Huntington Medical Foundation

N

Southern California Heart Specialists

N

Michael Gurevitch

N

Sylvia Preciado

N

Asclepion Family Medical Group Inc.

N

ACO Governing BodyCorp

Member

Member's Voting Power

Membership Type

ACO Participant TIN Legal Business Name/DBA, if Applicable

Last Name

First Name

Title/Position

Pachorek

Joseph

Board Chair

1

ACO participant representative

Joseph J Pachorek A California Medical Corporation

Miller

Stuart

Board Vice Chair

1

ACO participant representative

Huntington Medical Foundation

Tilem

Claire

Secretary Treasurer

1

ACO participant representative

Huntington Medical Foundation

Alrashid

Wufaa

Co-Chair Quality Assurance

1

ACO participant representative

Wufaa Alrashid MD Inc

Siew

Robert

Co-Chair Membership

1

ACO participant representative

Robert Siew MD

Henry

Stephen

Co-Chair Finance

1

ACO participant representative

SD Henry

Verrette

Paula

Hospital Member

1

ACO participant representative

Pasadena Hospital Association Ltd

Takhar

Raj

Hospital Member

1

ACO participant representative

Pasadena Hospital Association Ltd

Berg

Brenda

Community Member

1

Medicare beneficiary representative

n/a

Manvelyan

Marina

Member at Large

1

ACO participant representative

Washington Medical Group

Rowady

Daniel

Member at Large

1

ACO participant representative

Joseph J Pachorek A California Medical Corporation

Durairaj

Azhil

Member at Large

1

ACO participant representative

Foothill Cardiology California Heart Medical Group Inc

Giesler

Gregory

Co-Chair Quality Assurance

1

ACO participant representative

Southern California Heart Specialists

Moore

Ann

Co-Chair Membership

1

ACO participant representative

Pasadena Nephrology Corporation A Medical Group

Ohanian

Arbi

Member at Large

1

ACO participant representative

Southern California Neurology Medical Group Inc

Patel

Ashish

Co-Chair Finance

1

ACO participant representative

Ashish B Patel MD Inc

Minazad

Yafa

Member at Large

1

ACO participant representative

Southern California Neurology Medical Group Inc

Alza

Gustavo

Co-Chair Care Continuum

1

ACO participant representative

Gustavo A Alza A Med Corp

Chandrasoma

Brooke

Co-Chair Care Continuum

1

ACO participant representative

Huntington Pulmonary Medical Group

Key ACO clinical and administrative leadership:

Gabriella Sherman, MD

ACO Executive

Wufaa Alrashid, MD

Medical Director

Terence Ou

Compliance Officer

Kapinga Brown

Quality Assurance/Improvement Officer

Associated Committees and Committee Leadership:

Committee Name

Committee Leader Name and Position

Quality

Wufaa Alrashid, MD & Gregory Giesler, MD:  Co-Chairs

Continuum of Care

Gustavo Alza, MD & Brooke Chandrasoma, MD: Co-Chairs

Membership

Robert Siew, MD & Ann Moore, MD: Co-Chairs

Finance, Compliance and Contracting

Stephen Henry, MD & Ashish Patel, MD: Co-Chairs

Types of ACO participants, or combinations of participants, that formed the ACO:

  • Partnership arrangement between hospital and ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

  • First Agreement Period
    • Performance Year 2016, $0
    • Performance Year 2015, $0
    • Performance Year 2014, $0

Shared Savings Distribution

  • First Agreement Period
    • Performance Year 2016
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2015
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2014
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A

Quality Performance Results

2016 Quality Performance Results:

ACO#

Measure Name

Rate

ACO Mean

ACO-1

CAHPS: Getting Timely Care, Appointments, and Information

84.88

80.51

ACO-2

CAHPS: How Well Your Providers Communicate

93.24

93.01

ACO-3

CAHPS: Patients’ Rating of Provider

93.32

92.25

ACO-4

CAHPS: Access to Specialists

82.11

83.49

ACO-5

CAHPS: Health Promotion and Education

62.44

60.32

ACO-6

CAHPS: Shared Decision Making

76.77

75.40

ACO-7

CAHPS: Health Status/Functional Status

74.23

72.30

ACO-34

CAHPS: Stewardship of Patient Resources

27.31

26.97

ACO-8

Risk Standardized, All Condition Readmission

14.60

14.70

ACO-35

Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM)

18.13

18.17

ACO-36

All-Cause Unplanned Admissions for Patients with Diabetes

51.17

53.20

ACO-37

All-Cause Unplanned Admissions for Patients with Heart Failure

67.37

75.23

ACO-38

All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions

57.19

59.81

ACO-9

Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5)

7.5

9.27

ACO-10

Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8)

13.61

14.53

ACO-11

Percent of PCPs who Successfully Meet Meaningful Use Requirements

88.24

82.72

ACO-39

Documentation of Current Medications in the Medical Record

25.92

87.54

ACO-13

Falls: Screening for Future Fall Risk

58.55

64.04

ACO-14

Preventive Care and Screening: Influenza Immunization

60.30

68.32

ACO-15

Pneumonia Vaccination Status for Older Adults

72.91

69.21

ACO-16

Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up

70.28

74.45

ACO-17

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

93.73

90.98

ACO-18

Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan

49.91

53.63

ACO-19

Colorectal Cancer Screening

63.62

61.52

ACO-20

Breast Cancer Screening

78.93

67.61

ACO-21

Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented

61.11

76.79

ACO-42

Statin therapy for the Prevention and Treatment of Cardiovascular Disease

73.30

77.72

ACO-27

Diabetes Mellitus: Hemoglobin A1c Poor Control

11.48

18.24

ACO-41

Diabetes: Eye Exam

37.10

44.94

ACO-28

Hypertension (HTN): Controlling High Blood Pressure

68.03

70.69

ACO-30

Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic

87.77

85.05

ACO-31

Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

100.00

88.67

ACO-33

Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%)

83.67

79.67

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.   

Note: In the Quality Performance Results file(s) above, search for “Huntington Care Network ACO, LLC” to view the quality performance results. This ACO can also be found by using the ACO ID A53129 in the public use files on data.cms.gov.

Payment Rule Waivers

  • No, our ACO does not use the SNF 3-Day Rule Waiver.

Waiver Notices